Background Image
Table of Contents Table of Contents
Previous Page  13 / 68 Next Page
Information
Show Menu
Previous Page 13 / 68 Next Page
Page Background

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 26, No 3, May/June 2015

AFRICA

111

Results

NAFLD was diagnosed in 32 individuals (15 males, 17 females;

mean age 50

±

9 years; 59% with grade I HS, 41% grade II–III

HS) by means of ultrasonography data. Twenty-two individuals

whose ultrasonography data did not show HS comprised the

control group (11 males, 11 females; mean age 50

±

10 years) and

were included in the study.

Clinical characteristics of the 32 NAFLD patients and 22

control subjects are presented in Table 2. Age, gender, body mass

index, diabetes mellitus, dyslipidaemia and smoking status were

similar between the NAFLD patients and controls. Additionally,

there were no significant differences with regard to laboratory

results (Table 2). When compared in terms of echocardiographic

features, the groups were similar in chamber diameter and

standard Doppler parameters (Table 3).

There were no significant differences for E, A, E/A and DT

between the patients and controls. For tissue Doppler parameters,

the Ea and Ea/Aa were lower in the patient group than in the

control group (

p

<

0.001,

p

<

0.001, respectively). Isovolumetric

relaxation time (IVRT) and MPI were significantly higher (

p

=

0.002,

p

<

0.001, respectively) in the patient group. There

were no significant differences for Aa, DTa, Sa, isovolumetric

contraction time (IVCT) and contraction time (CT) between the

two groups. Tissue Doppler parameters are presented in Table 4.

Grade of HS was positively correlated with right ventricular

isovolumetric relaxation time and MPI (

r

=

0.295,

p

=

0.03,

r

=

0.641,

p

<

0.001, respectively). Correlations between grade of HS

and echocardiographic parameters are shown in Table 5.

Table 1. Conventional and tissue Doppler

echocardiographic parameters and their implications

on right ventricular systolic and diastolic function

Parameters

Systolic

function

Diastolic

function

Conventional echocardiography

Tricuspid E

+

Tricuspid Aa

+

Tricuspid E/A

+

Tricuspid E DT

+

Tissue Doppler imaging

RV S

+

RV Ea

+

RV Aa

+

RV Ea

/Aa

+

RV deceleration time (ms)

+

Isovolumetric relaxation time (ms)

+

Isovolumetric contraction time (ms)

+

Contraction time (ms)

+

Myocardial performance index

+

+

Tricuspid E: peak velocity of early diastolic filling, tricuspid A: peak

velocity of atrial diastolic filling, tricuspid E DT: deceleration time of

early diastolic filling, Ea: tricuspid lateral annulus early diastolic wave,

Aa: tricuspid lateral annulus late diastolic wave, DT: tricuspid lateral

annulus E-wave deceleration time, RV: right ventricular.

Table 2. Demographic and clinical characteristics of the groups

Parameters

Patient

group

(

n

=

32)

Control

group

(

n

=

22)

p-

value

Mean age (years)

50

±

9

51

±

10 0.979

Gender M/F

15/17

11/11

0.821

Body mass index (kg/m²)

29.8

±

3.4 28.2

±

3.2 0.094

Smoking,

n

(%)

5 (15)

7 (31)

0.160

Hypertension,

n

(%)

6 (18)

6 (27)

0.459

Diabetes mellitus

n

(%)

4 (12)

3 (13)

0.903

Dyslipidaemia,

n

(%)

11 (34)

5 (22)

0.357

Glucose (mg/dl)

105.4

±

21.4 102.8

±

28.9

(mmol/l)

5.85

±

1.19 5.71

±

1.60 0.174

AST (U/l)

25.7

±

6.9 25.2

±

7.4 0.711

ALT (U/l)

28.5

±

12.1 26.1

±

12.2 0.459

LDH (U/l)

159.5

±

21.7 156.3

±

17.8 0.672

Haemoglobin (g/dl)

14.1

±

1.1 13.8

±

1.3 0.622

Total cholesterol (mg/dl)

200.7

±

40.3 184.3

±

40.3 0.119

(mmol/l)

5.20

±

1.04 4.77

±

1.04

Triglyceride (mg/dl)

184

±

85.5 158.4

±

77.9 0.189

(mmol/l)

2.08

±

0.97 1.79

±

0.88

High-density lipoprotein (mg/dl)

40

±

8.8 39.5

±

11.2 0.433

(mmol/l)

1.04

±

0.23 1.02

±

0.29

Low-density lipoprotein (mg/dl) 124.7

±

35 113.4

±

35.8 0.144

(mmol/l)

3.23

±

0.91 2.94

±

0.93

AST: aspartate aminotransferase, ALT: alanine transaminase, LDH:

lactate dehydrogenase.

Table 3. Echocardiographic parameters between

the patient group and the control group

Parameters

Patient group

Control group

p-

value

LVEDD (mm)

48.07

±

3.82

48.47

±

3.95 0.986

LVESD (mm)

29.8

±

4.78

30.43

±

4.22 0.140

IVS (mm)

10.08

±

1.33

9.90

±

1.19 0.720

LVEF (%)

68.01

±

7.01

66.31

±

6.59 0.762

RVEDD (mm)

28.78

±

3.15

28.47

±

3.67 0.523

LA diameter (mm)

36.35

±

3.81

36.94

±

3.08 0.710

RA diameter (mm)

32.99

±

4.93

31.31

±

4.72 0.535

Tricuspid E (cm/s)

55.8

±

12.6

54.6

±

8.3

0.888

Tricuspid A (cm/s)

47

±

13

41.7

±

9.6

0.156

Tricuspid E/A ratio

1.2

±

0.4

1.3

±

0.3

0.413

Tricuspid E DT (ms)

190.2

±

30.4

193.6

±

19.5 0.365

LVEDD: left ventricular end-diastolic diameter, LVESD: left ventric-

ular end-systolic diameter, IVS: interventricular septum, LVEF: left

ventricular ejection fraction, RVEDD: right ventricular end-diastolic

diameter, LA: left atrium, RA: right atrium, tricuspid E: peak velocity

of early diastolic filling, tricuspid A: peak velocity of atrial diastolic

filling, tricuspid E DT: deceleration time of early diastolic filling.

Table 4. Right ventricular tissue Doppler

echocardiographic parameters

Parameters

Patient

group

Control

group

p-

value

RV S-wave peak velocity (cm/s)

13.8

±

2.1 14.3

±

2.1 0.476

RV Ea-wave peak velocity (cm/s) 12.1

±

3.1

14

±

3.1 0.03

RV Aa-wave peak velocity (cm/s) 17.2

±

3.6 15.5

±

3.9 0.061

RV Ea/Aa ratio

0.7

±

0.3 0.9

±

0.4 0.02

Ea DT (ms)

166.2

±

27.7 167.2

±

22.7 0.679

IVRT (ms)

77.3

±

8.5 61.5

±

4.3

<

0.001

IVCT (ms)

66.4

±

8.7 62.8

±

9.9 0.072

CT (ms)

295.5

±

27.6 302.1

±

23 5 0.610

Tei index LV

0.50

±

0.05 0.42

±

0.03

<

0.001

RV: right ventricular, Ea: tricuspid lateral annulus early diastolic wave,

Aa: tricuspid lateral annulus late diastolic wave, DT: tricuspid lateral

annulus E-wave deceleration time, IVRT: isovolumetric relaxation

time, IVCT: isovolumetric contraction time, CT: contraction time.